New one-year results from 413 patients in the global EXPAND study of Abbott’s next-generation MitraClip mitral valve repair system demonstrate the benefits of MitraClip in a broad population of patients with functional (secondary) mitral regurgitation (MR).
The study, which is the largest contemporary real-world study of the MitraClip NTR/XTR system, showed that mitral valve repair with the system led to significant reductions in MR and improvements...